-
albuterol
- trade name: Proventil
- ID: adrenergic
- bronchodilator
- vasodilator
- smooth muscle relaxer
- therapy: short acting
- acute asthma attack
- principle I
- dose: every 3 hrs
- target: beta2-receptors in airways
- action: bronchodilation
- decrease smooth muscle contraction
- promote smooth muscle relaxtion
- glucogenolysis
- lungs
- smooth muscle
- risk: HTN
- diabetes 2
-
loratinide
- trade: Claritin
- ID: antihistamines
- 2nd generation Benadryl
- therapy: seasonal allergies
- action: blocks peripheral effects of CNX Vagus
- selective H1 blockers
- treat symptoms
- sneezing
- rhinorrhea
- nasal/ocular pruritis
- ocular tearing/redness
- urticaria
- contraindication: liver disease
- hypersensitivity
- risk: drowsy (rare)
-
prednisone
- drug: corticosteroid
- ID: glucocorticoid hormone
- antiasthmatics
- anti-inflammatory
- antiallergenic
- therapy: systemic treatment
- acute asthma
- principle III
- supplement use of beta2 adrenergics
- and of anticholingerics
- later-end stages of COPD
- target: Cortisol
- action: suppress tissue inflammation
- relax smooth muscle
- increase Cortisol
- location: tissue
- lungs
- contraindicated: diabetes
- risk: dependence
- long term adverse effects
- increased wound healing time
-
epinephrine
- trade name: Primatene Mist
- ID: vasopressors
- bronchodilators
- antiasthmatics
- adrenergics
- route: subcutaneous [emergency]
- inhalent
- therapy: asthma
- fasting acting inhaler
- principle I
- dose: nebulizer
- aerosol
- every 3 hrs
- injection [emergency]
- action: non-selective
- beta1/beta2 adrenergic agonist
- vasopressors
- vasoconstriction
- bronchodilation
- location: heart
- lungs
- risk: paradoxical bronchospasm
- tachycardia
- abuse
-
-
ipratropium
- trade: Atrovent
- ID: anticholinergic
- route: nasal inhalant
- therapy: chronic asthma
- COPD
- combo w beta2 adrenergic bronchodilators
- supplement use with corticosteroids
- action: block CNX Vagus Parasympathetic
- suppress bronchoconstrictor activity
- dilate smooth muscle
- location: lungs
- bronchi
- bronchioles
- risk: dry mouth
- sore throat
-
beclomethasone
- trade: Vanceril
- ID: corticosteroid
- antiasthmatics
- anti-inflammatories
- therapy: chronic asthma
- COPD
- prophylaxis
- maintenance
- principle II
- reduce need for systemic corticoid use
- also treats allergic rhinitis
- action: low systemic absorption
- risks: minimal
- hypersensitivity
- thrush
-
loratidine
- trade: Claritin
- ID: second generation
|
|